Increased percentages of B lymphocytes (CD19+) [22] and increased levels of TGF-β in blood plasma [19] were observed in our studies of young tumor-bearing mice treated with vitamin D analogs, whereas the number of CD19+ cells [18] and the level of TGF-β in old mice were not affected [20]. The gene discussed is TGFB1; the disease is neoplasm.